500087 Stock Overview
Manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 500087 from our risk checks.
Cipla Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,480.40 |
| 52 Week High | ₹1,581.70 |
| 52 Week Low | ₹997.00 |
| Beta | 0.37 |
| 11 Month Change | 2.23% |
| 3 Month Change | -1.07% |
| 1 Year Change | 45.79% |
| 33 Year Change | 51.20% |
| 5 Year Change | 169.19% |
| Change since IPO | 1,654.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| 500087 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.9% | 0.9% | 1.1% |
| 1Y | 45.8% | 46.8% | 44.4% |
Return vs Industry: 500087 underperformed the Indian Pharmaceuticals industry which returned 46.8% over the past year.
Return vs Market: 500087 exceeded the Indian Market which returned 44.4% over the past year.
Price Volatility
| 500087 volatility | |
|---|---|
| 500087 Average Weekly Movement | 3.7% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.6% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 500087 has not had significant price volatility in the past 3 months.
Volatility Over Time: 500087's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1935 | 32,323 | Umang Vohra | www.cipla.com |
Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry.
Cipla Limited Fundamentals Summary
| 500087 fundamental statistics | |
|---|---|
| Market cap | ₹1.20t |
| Earnings (TTM) | ₹41.22b |
| Revenue (TTM) | ₹254.47b |
29.0x
P/E Ratio4.7x
P/S RatioIs 500087 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500087 income statement (TTM) | |
|---|---|
| Revenue | ₹254.47b |
| Cost of Revenue | ₹88.20b |
| Gross Profit | ₹166.27b |
| Other Expenses | ₹125.06b |
| Earnings | ₹41.22b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 51.04 |
| Gross Margin | 65.34% |
| Net Profit Margin | 16.20% |
| Debt/Equity Ratio | 0.9% |
How did 500087 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield25%
Payout RatioDoes 500087 pay a reliable dividends?
See 500087 dividend history and benchmarks| Cipla dividend dates | |
|---|---|
| Ex Dividend Date | Aug 02 2024 |
| Dividend Pay Date | Sep 19 2024 |
| Days until Ex dividend | 33 days |
| Days until Dividend pay date | 81 days |
Does 500087 pay a reliable dividends?
See 500087 dividend history and benchmarks